Low impact
Johnson & Johnson's autoimmune drug received FDA approval for treatment of a rare blood disease.
Finnhub08/27, 12:50 PM
Related assets
Coming up for JNJ
Explore next
Latest JNJ news
FirstSquawk08/08, 08:14 AM
Duato sold 41,957 J&J shares at an average price of $258.06.
FirstSquawk08/08, 08:13 AM
J&J's Duato disclosed a share sale of $1.69M at an average price of $258.74.
ZeroHedge08/03, 05:13 PM